Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 12, 2018
Patent Application Number
15274330
Date Filed
September 23, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides antibodies and antigen-binding fragments thereof that bind to the antibody pembrolizumab (pembrolizumab). These antibodies are useful, for example, for use as positive controls in assays for detecting the presence of anti-drug antibodies in a sample, e.g., the blood of a patient who has been administered pembrolizumab.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
